Tumor regression and allograft rejection after administration of anti–PD-1
EJ Lipson, SM Bagnasco, J Moore Jr… - … England Journal of …, 2016 - Mass Medical Soc
New England Journal of Medicine, 2016•Mass Medical Soc
Tumor Regression and Allograft Rejection after Administration of Anti–PD-1 | New England
Journal of Medicine Skip to main content The New England Journal of Medicine homepage
Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine Emergency Medicine
Endocrinology Gastroenterology Hematology/Oncology Infectious Disease Nephrology
Neurology/Neurosurgery Obstetrics/Gynecology Pediatrics Pulmonary/Critical Care View All
Specialties TOPICS AI in Medicine Climate Crisis and Health Coronavirus Fundamentals of Health …
Journal of Medicine Skip to main content The New England Journal of Medicine homepage
Advanced Search SEARCH SPECIALTIES Cardiology Clinical Medicine Emergency Medicine
Endocrinology Gastroenterology Hematology/Oncology Infectious Disease Nephrology
Neurology/Neurosurgery Obstetrics/Gynecology Pediatrics Pulmonary/Critical Care View All
Specialties TOPICS AI in Medicine Climate Crisis and Health Coronavirus Fundamentals of Health …
Cancers, especially skin cancers, may develop in patients undergoing solid-organ transplantation who receive long-term immunosuppression. The use of anti–PD-1 in one such patient produced an antitumor response but led to rejection of the transplanted kidney.
The New England Journal Of Medicine